Åke Berglund - Concepedia

Author

Åke Berglund

Also Known As

A Berglund, A. Berglund, A. Scott Berglund, Ake Berglund, Ammie Berglund, Åke Berglund, Petra Flygare, À Berglund, Å Berglund, Å. Berglund

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Uppsala University Uppsala University Hospital Karolinska Institutet Karolinska University Hospital Haukeland University Hospital

ÅB

About

Åke Berglund is an author at Uppsala University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	3.4K
2	Pathology	5	5	208
3	Health Sciences	3	3	167
4	Cellular Therapies	1	1	132
5	Marrow Transplantation	1	1	132

Åke Berglund

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, The Lancet Oncology Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineColorectal Cancer	2020	1.5K
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial Johan Erlandsson, Torbjörn Holm, David Pettersson, The Lancet Oncology Adaptive RadiotherapySurgical OncologyRadiation TherapyMedicineRectal Cancer	2017	610
Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer Morten Brændengen, Kjell M. Tveit, Åke Berglund, Journal of Clinical Oncology	2008	478
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery Esmée A. Dijkstra, Per J. Nilsson, Geke A.P. Hospers, Annals of Surgery	2023	309
Short-course preoperative radiotherapy with delayed surgery in rectal cancer – A retrospective study Calin Radu, Åke Berglund, Lars Påhlman, Radiotherapy and Oncology Radiation MedicineSurgical OncologyRadiation TherapyMedicineRectal Cancer	2008	217
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data Anne von Heideman, Åke Berglund, Rolf Larsson, Cancer Chemotherapy and Pharmacology MedicinePharmacologyClinical TrialsCancer DrugsPharmacotherapy	2009	190
High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas AK Blystad, Gunilla Enblad, Stein Kvaløy, Bone Marrow Transplantation Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationMedicine	2001	132
Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study Haile Mahteme, Johan Hansson, Åke Berglund, British Journal of Cancer	2004	127
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer Bengt Glimelius, Hans Garmo, Åke Berglund, The Pharmacogenomics Journal	2010	121
The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy Lennart Blomqvist, Anders Sundin, Hans Jacobsson, Annals of Oncology Surgical OncologyGastrointestinal OncologyMedicineTumor SizeColorectal Cancer	2011	106

Page 1